NBIX Earnings

Quarterly EPS
$1.28
Q3 2024
$1.03
Q4 2024
$0.08
Q1 2025
$1.09
Q2 2025
$2.11
Q3 2025
$1.54
Q4 2025
$1.97
Q1 2026
$1.43
Q2 2026
Latest Revenue959.0M
Latest Net Income144.4M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$1.43959.0M144.4M+39.5%+31.2%
Q1 2026$1.97814.5M197.9M+42.2%+2,362.5%
Q4 2025$1.54805.5M153.7M+28.3%+49.5%
Q3 2025$2.11794.9M209.5M+27.8%+64.8%
Q2 2025$1.09687.5M107.5M+16.5%+70.3%
Q1 2025$0.08572.6M7.9M+11.1%-81.4%
Q4 2024$1.03627.7M103.1M+21.8%-31.3%
Q3 2024$1.28622.1M129.8M+24.7%+50.6%
Q2 2024$0.64590.2M65.0M
Q1 2024$0.43515.3M43.4M
Q4 2023$1.50515.2M147.7M
Q3 2023$0.85498.8M83.1M
Neurocrine Biosciences (NBIX) — Earnings